Delivery Order SPE2DB20D2104-SPE2DB21FT99Q
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,256.39 firm fixed-price delivery order is for the supply of Crestor 5 mg tablets to support military healthcare programs. The contract has an ultimate completion date of February 6, 2024 and was awarded on February 5, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract held by Cencora, Inc. with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,132.69 firm fixed-price delivery order is for the provision of Crestor 20 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,886.53, is for the delivery of Crestor 40 mg tablets. The contract is a delivery order and has a firm fixed price pricing type. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,166.89 firm fixed-price delivery order for 4,565,121,232 units of the prescription drug CRESTOR 20 MG TABLET 90S. The award was made by the Defense Logistics Agency (DLA), which provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a large pharmaceutical distribution company, holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,727.79 firm-fixed-price delivery order supports the procurement of CRESTOR 40 MG TABLET 30S, a cardiovascular medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., which enables the efficient...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,358.93 firm fixed-price delivery order is for the supply of CRESTOR 10 MG TABLET 90S, a cardiovascular medication, with a completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,090.69 firm fixed-price delivery order is for the supply of CRESTOR 20 MG TABLET 90S, a cardiovascular medication. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a $21,193.64 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Crestor 40 mg tablets, a cardiovascular medication, to support military treatment facilities and federal healthcare programs. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,194.68 firm fixed-price delivery order is for the supply of CRESTOR 10 MG TABLET 90S, a cardiovascular medication. The contract has an ultimate completion date of March 28, 2025 and was awarded on March 27, 2025 with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CRESTOR 20 MG TABLET 90S, a prescription medication, with a ceiling value of $2,845.98 and a period of performance through June 18, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB21FT99QDelivery Order
This federal contract award, valued at $2,304.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Crestor 20 mg tablets, a cardiovascular medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as a primary vehicle for Cencora, Inc. to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, Cencora, Inc. and its Amerisourcebergen Drug Corp subsidiary play a critical role in supplying essential medications and medical commodities to various federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/20/21 |